Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 24 May 2016 Global Antibiotic Research & Development Partnership (GARDP) garners key financial support for launch
Press releases 13 Apr 2016 Drugs for Neglected Diseases initiative and Pharco Pharmaceuticals to test affordable hepatitis C regimen with support of Malaysian and Thai governments
Press releases 13 Jan 2016 Clinical Research Malaysia and the Drugs for Neglected Diseases initiative sign agreement to launch clinical studies for a public health approach to hepatitis C in Malaysia
Press releases 14 Dec 2015 DNDi statement on KaloBios’ intention to raise price of Chagas drug and file for FDA priority review
Press releases 30 Nov 2015 World AIDS Day 2015: Study begins in Kenya for recently-approved paediatric HIV treatment
Press releases 16 Oct 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients at a key gathering of experts in India
Press releases 8 Oct 2015 French Development Agency AFD and DNDi sign partnership agreement for control of leishmaniasis in East Africa
Press releases 6 Oct 2015 DNDi awarded USD 2.34 million from new pooled fund mechanism at WHO-TDR in support of global leishmaniasis R&D demonstration project
Press releases 5 Oct 2015 DNDi applauds 2015 Nobel Prize winners for key advancements in fighting malaria, river blindness, and lymphatic filariasis
Press releases 10 Sep 2015 Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to test drug candidate for Eumycetoma
Press releases 8 Sep 2015 Pivotal clinical trial to begin for first oral drug candidate specifically developed for sleeping sickness
Press releases 7 Sep 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients
Press releases 3 Jun 2015 Child-friendly formulation of WHO-recommended treatment now approved by the US FDA for children living with HIV
Press releases 28 May 2015 DNDi and four pharmaceutical companies announce ‘Drug Discovery Booster’ experiment to accelerate and expand discovery of new drugs for two highly neglected diseases – leishmaniasis and Chagas disease
Press releases 11 May 2015 MSF and DNDi Join call for a biomedical research and development fund and mechanism to meet pressing global health needs
